ArticleFrontiers in public health2025
Control and determinants of the tobacco epidemic and the use of other tobacco products among children and adolescents in the Subcarpathian Voivodeship.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Quantitative electroencephalography as a next-generation tool in neurodiagnostics: significance, clinical applications, and practical interpretative frameworks.Frontiers in neuroscience · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tobacco smoking remains one of the most significant public health challenges, particularly among children and adolescents, for whom early smoking initiation increases the risk of long-term addiction and severe health consequences. The aim of this study was to assess the prevalence of cigarette and other tobacco product use among adolescents aged 12-16 years in the Subcarpathian Voivodeship and to analyze the factors influencing this phenomenon. Materials and method: The study involved a survey conducted among 865 students aged 12-16 years from the Subcarpathian Voivodeship. The research tool was a questionnaire comprising 79 questions addressing nicotine initiation, tobacco product availability, and peer behaviors. Data were collected between March and November 2019. Educational institutions were randomly selected, and parents or legal guardians were informed via an electronic journal. The study was conducted with the consent of the Subcarpathian Education Authority and the Bioethics Committee of the University of Rzeszow. Results: The results indicated that 19.2% of respondents had experimented with cigarettes, with an average initiation age of 14 years. Notably, 31.1% of participants perceived e-cigarettes as less harmful than traditional cigarettes, highlighting the need for more intensive health education efforts. Most respondents reported smoking initiation due to peer influence, and some were able to purchase cigarettes independently, despite legal restrictions. Conclusion: The findings underscore the urgent need to intensify preventive measures, strengthen health education, and enhance enforcement of tobacco sales regulations to effectively curb the tobacco epidemic among the youngest populations. Implications: The study provides valuable data on the factors influencing tobacco and other tobacco product use among children and adolescents in the Subcarpathian Voivodeship. The findings highlight the crucial role of the social environment, access to tobacco products, and the effectiveness of preventive measures. The obtained data may serve as a basis for developing more effective tobacco prevention strategies for young people, as well as for implementing educational programs and policy interventions aimed at reducing the availability and attractiveness of tobacco products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.